SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001438533-20-000029
Filing Date
2020-11-05
Accepted
2020-11-05 16:14:23
Documents
16
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rtrx-20201105.htm   iXBRL 8-K 41362
2 EX-99.1 a2020q3ex991.htm EX-99.1 191128
8 retrophinlogoa411a.jpg GRAPHIC 23393
  Complete submission text file 0001438533-20-000029.txt   430990

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20201105.xsd EX-101.SCH 2498
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20201105_cal.xml EX-101.CAL 781
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20201105_def.xml EX-101.DEF 1737
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20201105_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20201105_pre.xml EX-101.PRE 13261
9 EXTRACTED XBRL INSTANCE DOCUMENT rtrx-20201105_htm.xml XML 11216
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 201290611
SIC: 2834 Pharmaceutical Preparations